|
Market Closed -
OTC Markets
03:58:20 27/10/2026 HKT
|
5-day change | 1st Jan Change | ||
| 0.0251 USD | -16.33% |
|
-28.29% | -3.46% |
| 05-19 | Adaptimmune Therapeutics plc Reports Earnings Results for the Full Year Ended December 31, 2025 | CI |
| 11-17 | Adaptimmune Therapeutics plc Announces CEO Changes | CI |
Stock exchange
OTC Markets
ADAP.Y 0.0251 $
-16.33%
8.55K
$
| Markets | Price | Change | Volumes | ||
|---|---|---|---|---|---|
| ADAP.Y | 0.0251USD | -16.33% | 8.55K $ |
Quotes 5-day view: Adaptimmune Therapeutics plc
Delayed Quote OTC Markets
| 20/10/2026 | 21/10/2026 | 22/10/2026 | 23/10/2026 | 26/10/2026 | |
|---|---|---|---|---|---|
| Last | US$0.0325 | US$0.0320 | US$0.0250 | US$0.0300 | US$0.0251 |
| Volume | 80,262 | 187,723 | 628,856 | 41,951 | 340,808 |
| Change | -7.14% | -1.54% | -21.87% | +20.00% | -16.33% |
| Opening | US$0.0275 | US$0.0275 | US$0.0280 | US$0.0316 | US$0.0250 |
| High | US$0.0330 | US$0.0325 | US$0.0329 | US$0.0316 | US$0.0300 |
| Low | US$0.0275 | US$0.0275 | US$0.0204 | US$0.0250 | US$0.0250 |
Performance
| 1 day | -16.33% | ||
| 1 week | -28.29% | ||
| Current month | -33.95% | ||
| 1 month | -1.57% | ||
| 3 months | -14.04% | ||
| 6 months | +151.00% | ||
| Current year | -3.46% | ||
| 1 year | -61.21% | ||
| 3 years | -95.52% | ||
| 5 years | -99.50% | ||
| 10 years | -99.49% |
Volumes
marketsDaily volume
340,808
Estimated daily volume
340,808
Avg. Volume 20 sessions
193,134
Daily volume ratio
1.76
Avg. Volume 20 sessions USD
4,847.66
Record volume 1
825,386,452
Record volume 2
556,930,770
Record volume 3
516,546,145
Capital turnover ratio
0
Float rotation
0
Basic data
Market Cap (USD)
7,951,547
Net sales (USD)
5,924,000
Number of employees
272
Sales / Employee (USD)
21,779
Free-Float
14.03%
Free-Float capitalization (USD)
6,691,324
Average Daily Capital Traded
0.06%
Indicators
Moving average 5 days
0.0289
Moving average 20 days
0.031
Moving average 50 days
0.0278
Moving average 100 days
0.0305
Price spread / (MMA5)
+15.14%
Price spread / (MMA20)
+23.51%
Price spread / (MMA50)
+10.76%
Price spread / (MMA100)
+21.51%
STIM
RSI 9 days
49.65
RSI 14 days
50.55
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -16.33% | -28.29% | -61.21% | -95.52% | 7.95M | |
| +0.45% | +3.13% | +54.96% | +125.16% | 1,135B | |
| +0.94% | +4.93% | +39.86% | +78.72% | 635B | |
| +0.39% | +1.44% | +25.77% | +97.48% | 505B | |
| +1.43% | +4.31% | +46.20% | +67.12% | 378B | |
| -3.21% | -2.10% | +60.72% | +33.22% | 358B | |
| -0.41% | +2.64% | +22.48% | +49.82% | 295B | |
| +0.23% | +3.66% | +2.57% | +23.69% | 266B | |
| +1.22% | +4.63% | +52.40% | +64.85% | 237B | |
| +1.70% | +3.67% | +31.21% | +102.15% | 193B | |
| Average | -1.39% | -0.32% | +27.50% | +54.67% | 400.37B | |
| Weighted average by Cap. | +0.42% | +2.85% | +41.40% | +83.61% |
Historical Quotes: Adaptimmune Therapeutics plc
| Date | Opening | High | Low | Close | Volume | Change |
|---|
Latest transactions
5534f7eaeb0e08e4ca.8Q-LTdx8s3rp0r9wnYfVIxHA9Z0AbdWxoSycDGJaUeo.m0bjBu4u2SWgjY5J2f_4RGmHwqlqFbPc12rkVRY7HMepaNEiqTL3OcSr8g
| Date | Price | Volume | Total |
|---|---|---|---|
| 03:58:20 | 0.0251 | 2,832 | 340,194 |
| 03:58:11 | 0.0299 | 100 | 337,362 |
| 03:43:03 | 0.0299 | 100 | 337,262 |
| 03:42:58 | 0.0275 | 6,258 | 337,162 |
| 03:38:32 | 0.0299 | 100 | 330,904 |
| 03:35:45 | 0.0251 | 197,954 | 330,804 |
| 03:35:44 | 0.0251 | 10,000 | 132,850 |
| 03:35:10 | 0.0299 | 100 | 122,850 |
| 03:31:30 | 0.0251 | 157 | 122,750 |
| 03:19:50 | 0.0299 | 100 | 122,593 |
Price Extremes
| 1 week | 0.02 |  | 0.03 |
| 1 month | 0 | | 0.04 |
| Current year | 0 | | 0.05 |
| 1 year | 0 | | 0.07 |
| 3 years | 0 | | 2.05 |
| 5 years | 0 | | 5.95 |
| 10 years | 0 | | 14.62 |
Monthly variations
Annual variations
| 2026 | -3.46% | ||
| 2025 | -95.17% | ||
| 2024 | -32.07% | ||
| 2023 | -45.68% | ||
| 2022 | -61.07% | ||
| 2021 | -30.43% | ||
| 2020 | +349.17% | ||
| 2019 | -79.13% | ||
| 2018 | -13.92% | ||
| 2017 | +64.94% | ||
| 2016 | -66.42% | ||
| 2015 | -30.01% |
- Stock Market
- Stocks
- ADAP.Y Stock
- Quotes Adaptimmune Therapeutics plc
Select your edition
All financial news and data tailored to specific country editions
